Cargando…
Skin Barrier Dysregulation in Psoriasis
The skin barrier is broadly composed of two elements—a physical barrier mostly localised in the epidermis, and an immune barrier localised in both the dermis and epidermis. These two systems interact cooperatively to maintain skin homeostasis and overall human health. However, if dysregulated, sever...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509518/ https://www.ncbi.nlm.nih.gov/pubmed/34639182 http://dx.doi.org/10.3390/ijms221910841 |
_version_ | 1784582361122340864 |
---|---|
author | Orsmond, Andreas Bereza-Malcolm, Lara Lynch, Tom March, Lyn Xue, Meilang |
author_facet | Orsmond, Andreas Bereza-Malcolm, Lara Lynch, Tom March, Lyn Xue, Meilang |
author_sort | Orsmond, Andreas |
collection | PubMed |
description | The skin barrier is broadly composed of two elements—a physical barrier mostly localised in the epidermis, and an immune barrier localised in both the dermis and epidermis. These two systems interact cooperatively to maintain skin homeostasis and overall human health. However, if dysregulated, several skin diseases may arise. Psoriasis is one of the most prevalent skin diseases associated with disrupted barrier function. It is characterised by the formation of psoriatic lesions, the aberrant differentiation and proliferation of keratinocytes, and excessive inflammation. In this review, we summarize recent discoveries in disease pathogenesis, including the contribution of keratinocytes, immune cells, genetic and environmental factors, and how they advance current and future treatments. |
format | Online Article Text |
id | pubmed-8509518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85095182021-10-13 Skin Barrier Dysregulation in Psoriasis Orsmond, Andreas Bereza-Malcolm, Lara Lynch, Tom March, Lyn Xue, Meilang Int J Mol Sci Review The skin barrier is broadly composed of two elements—a physical barrier mostly localised in the epidermis, and an immune barrier localised in both the dermis and epidermis. These two systems interact cooperatively to maintain skin homeostasis and overall human health. However, if dysregulated, several skin diseases may arise. Psoriasis is one of the most prevalent skin diseases associated with disrupted barrier function. It is characterised by the formation of psoriatic lesions, the aberrant differentiation and proliferation of keratinocytes, and excessive inflammation. In this review, we summarize recent discoveries in disease pathogenesis, including the contribution of keratinocytes, immune cells, genetic and environmental factors, and how they advance current and future treatments. MDPI 2021-10-07 /pmc/articles/PMC8509518/ /pubmed/34639182 http://dx.doi.org/10.3390/ijms221910841 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Orsmond, Andreas Bereza-Malcolm, Lara Lynch, Tom March, Lyn Xue, Meilang Skin Barrier Dysregulation in Psoriasis |
title | Skin Barrier Dysregulation in Psoriasis |
title_full | Skin Barrier Dysregulation in Psoriasis |
title_fullStr | Skin Barrier Dysregulation in Psoriasis |
title_full_unstemmed | Skin Barrier Dysregulation in Psoriasis |
title_short | Skin Barrier Dysregulation in Psoriasis |
title_sort | skin barrier dysregulation in psoriasis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509518/ https://www.ncbi.nlm.nih.gov/pubmed/34639182 http://dx.doi.org/10.3390/ijms221910841 |
work_keys_str_mv | AT orsmondandreas skinbarrierdysregulationinpsoriasis AT berezamalcolmlara skinbarrierdysregulationinpsoriasis AT lynchtom skinbarrierdysregulationinpsoriasis AT marchlyn skinbarrierdysregulationinpsoriasis AT xuemeilang skinbarrierdysregulationinpsoriasis |